{
  "docId": "019de071-f648-72d0-9c84-3373768bf908",
  "docSlug": "15eb2f0f83943ed61260bacd75adb779",
  "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 23,
  "pageCount": 42,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "other",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a process flow to map research/clinical stages to specific de-risking milestones.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/23",
  "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908",
  "deckJsonHref": "/decks/019de071-f648-72d0-9c84-3373768bf908.json",
  "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.35,
        "x": 0.11,
        "y": 0.23
      },
      "kind": "diagram",
      "text": "Sequential stages from In vitro to Phase 2a CIAS",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "73321494-6aa5-4413-9301-e193a85b557c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.35,
        "x": 0.54,
        "y": 0.24
      },
      "kind": "list",
      "text": "Consistent PK-PD relationship; Confidence in active dose range; Complete CMC package; Excellent tolerability and safety; Multiple clinical cognitive signals; De-risked path forward",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad88feea-c63e-42a1-a6cf-481e9d85b2bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "RL – 007 de-risked through extensive & consistent translational data",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e814650c-2748-47eb-b290-189ea20867f6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "1099cddd-39fc-4eb8-86cd-7fe3f04d653d",
      "evidence": "diagram/process: Sequential stages from In vitro to Phase 2a CIAS",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "2d5881ed-5b55-441d-ac06-f79c8d4555fc",
      "evidence": "Sequential flow of clinical development stages",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 28,
      "from": 21,
      "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}